Back to top
more

Beyond Air (XAIR)

(Real Time Quote from BATS)

$1.25 USD

1.25
92,155

+0.06 (5.04%)

Updated Apr 19, 2024 01:02 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy18.00%
3Hold9.44%
4Sell5.10%
5Strong Sell2.53%
S&P50011.08%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value D Growth A Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (84 out of 250)

Industry: Medical - Biomedical and Genetics

Better trading starts here.

Zacks News

Beyond Air (XAIR) Upgraded to Buy: What Does It Mean for the Stock?

Beyond Air (XAIR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Beyond Air, Inc. (XAIR) Reports Q3 Loss, Misses Revenue Estimates

Beyond Air, Inc. (XAIR) delivered earnings and revenue surprises of 18.03% and 20.20%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Beyond Air, Inc. (XAIR) Reports Q1 Loss, Lags Revenue Estimates

Beyond Air, Inc. (XAIR) delivered earnings and revenue surprises of 2.17% and 70.65%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Beyond Air, Inc. (XAIR) Reports Q4 Loss, Lags Revenue Estimates

Beyond Air, Inc. (XAIR) delivered earnings and revenue surprises of -52.27% and 100%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Beyond Air, Inc. (XAIR) Reports Q3 Loss, Lags Revenue Estimates

Beyond Air, Inc. (XAIR) delivered earnings and revenue surprises of -2.38% and 100%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

New Strong Sell Stocks for January 27th

ARAY, XAIR, and EMKR have been added to the Zacks Rank #5 (Strong Sell) List on January 27, 2022

Implied Volatility Surging for Beyond Air (XAIR) Stock Options

Investors need to pay close attention to Beyond Air (XAIR) stock based on the movements in the options market lately.

Beyond Air, Inc. (XAIR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Beyond Air, Inc. (XAIR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Beyond Air, Inc. (XAIR) Reports Q1 Loss, Lags Revenue Estimates

Beyond Air, Inc. (XAIR) delivered earnings and revenue surprises of -63.16% and -100.00%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Will Beyond Air, Inc. (XAIR) Report Negative Earnings Next Week? What You Should Know

Beyond Air, Inc. (XAIR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Beyond Air (XAIR) is in Overbought Territory: What's Next?

Beyond Air (XAIR) has moved higher as of late, but there could definitely be trouble on the horizon for this company

Will Beyond Air, Inc. (XAIR) Report Negative Earnings Next Week? What You Should Know

Beyond Air, Inc. (XAIR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Share Gain in Core Markets to Aid Medtronic (MDT) Q4 Earnings

Growing momentum in capital equipment purchases might have aided Medtronic (MDT) Q4 earnings.

4 Biotech Stocks Set to Outpace Q1 Earnings Estimates

Let us take a look at some drug/biotech stocks that are poised to beat on first-quarter earnings.

Beyond Air, Inc. (XAIR) Reports Q3 Loss, Misses Revenue Estimates

Beyond Air, Inc. (XAIR) delivered earnings and revenue surprises of -6.45% and -25.50%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Beyond Air, Inc. (XAIR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Beyond Air, Inc. (XAIR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will AIT Therapeutics, Inc. (XAIR) Report Negative Earnings Next Week? What You Should Know

AIT Therapeutics, Inc. (XAIR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate AIT Therapeutics, Inc. (XAIR) to Report a Decline in Earnings: What to Look Out for

AIT Therapeutics, Inc. (XAIR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AIT Therapeutics, Inc. (XAIR) Reports Q3 Loss, Lags Revenue Estimates

AIT Therapeutics, Inc. (XAIR) delivered earnings and revenue surprises of -30.30% and -45.39%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

AIT Therapeutics, Inc. (XAIR) Reports Q2 Loss, Tops Revenue Estimates

AIT Therapeutics, Inc. (XAIR) delivered earnings and revenue surprises of -15.15% and 3.36%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

AIT Therapeutics, Inc. (XAIR) Reports Q1 Loss, Misses Revenue Estimates

AIT Therapeutics, Inc. (XAIR) delivered earnings and revenue surprises of -90.91% and -49.84%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?